Kedves Kollégák!

Lassan eltelt egy év, hogy a Fiatal Diabetológusok Fórumán találkoztunk. Hozzávetőlegesen 140-en voltunk Szegeden és igen jól éreztük magunkat. Sokat tanultunk.

Idén Pécs városa lesz a házigazda és ennek megfelelően számos előadó pécsi kolléga, elsősorban a Pécsi Tudományegyetemen dolgoznak. A diabéteszről általában, a kezeléséről, a diabétesszel összefüggő szövődményekről és társbetegségekről hallunk majd előadásokat.

A pécsi kollégák, amikor megkértem őket, megnézték a naptárukat, majd egyöntetűen igent mondtak felkérésünkre. Szinte minden felkért előadó vezetője egy tanszéknek. Köszönjük. Az előadók egy másik csoportja a Magyar Diabetes Társaság vezetőségi tagja, akik boldogan vállalták a fiatalok oktatását. És persze a társegyetemekről és kórházakból is a felkért előadók örömmel mondtak igent. Ezért ezt a rendezvényt szakmailag könnyű volt megszervezni.

Most ősszel sok a diabétesz rendezvény és nehéz az egészségügy anyagi helyzete, igy külön köszönjük azoknak a cégeknek, akik így is vállalták a szponzorálást.

DE EZ A RENDEZVÉNY MÁS, MINT A TÖBBI.

Okos, képzett oktatóktól tanuljuk a diabéteszt, és fogjuk hazánkban a betegeket egységes szemlélettel, okosan kezelni.

Este együtt vacsorázunk, kávézunk, beszélgetünk – kikapcsolódunk, jól érezzük magunkat.

GYERTEK EL FIATALOK!

Barátsággal:

Somogyi Anikó dr

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.

MCAS World Congress 2025 will gather in Paris for our next congress dedicated to medical aesthetics.

MCAS World Congress 2025 will gather in Paris for our next congress dedicated to medical aesthetics.